Kosuke Imamura
Kumamoto University
16 Papers
12 Citations
Kosuke Imamura is an academic researcher from Kumamoto University. The author has contributed to research in topics: Medicine & Lung cancer. The author has an hindex of 2, co-authored 8 publications.
Chat about Author
Papers
Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies
Ryo Sato,Kosuke Imamura,Shinya Sakata,Tokunori Ikeda,Yuko Horio,Shinji Iyama,Kimitaka Akaike,Shohei Hamada,Takayuki Jodai,Kei Nakashima,Shiho Ishizuka,Nahoko Sato,Koichi Saruwatari,Sho Saeki,Yusuke Tomita,Takuro Sakagami +15 more
TL;DR: A previously unrecognized pivotal role for immune activation in triggering disorders of the coagulation-fibrinolysis system in cancer patients during treatment with ICI is suggested.
68
Aging-associated and CD4 T-cell–dependent ectopic CXCL13 activation predisposes to anti–PD-1 therapy-induced adverse events
Hirotake Tsukamoto,Yoshihiro Komohara,Yusuke Tomita,Yuji Miura,Takanobu Motoshima,Kosuke Imamura,Toshiki Kimura,Tokunori Ikeda,Yukio Fujiwara,Hiromu Yano,Tomomi Kamba,Takuro Sakagami,Hiroyuki Oshiumi +12 more
TL;DR: It is found that in tumor-bearing aged, but not young, mice, anti–PD-(L)1 therapy alone induces irAE-like multiorgan toxicities through CD4 T-cell–derived interleukin (IL)-21 and subsequent age-specific CXCL13 expression in tertiary lymphoid structure.
41
Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies
Kosuke Imamura,Ryo Sato,Shinya Sakata,Tokunori Ikeda,Yuko Horio,Shinji Iyama,Kimitaka Akaike,Shohei Hamada,Takayuki Jodai,Kei Nakashima,Shiho Ishizuka,Nahoko Sato,Koichi Saruwatari,Sho Saeki,Yusuke Tomita,Hidenori Ichiyasu,Takuro Sakagami +16 more
- 01 May 2020
40
Heterogeneous Tumor-Immune Microenvironments between Primary and Metastatic Tumors in a Patient with ALK Rearrangement-Positive Large Cell Neuroendocrine Carcinoma.
Takahiro Tashiro,Kosuke Imamura,Yusuke Tomita,Daisuke Tamanoi,Akira Takaki,Kazuaki Sugahara,Ryo Sato,Koichi Saruwatari,Shinya Sakata,Megumi Inaba,Sunao Ushijima,Naomi Hirata,Takuro Sakagami +12 more
TL;DR: In this paper, a 32-year-old female patient with ALK-rearrangement-positive large cell neuroendocrine carcinoma (LCNEC) or anaplastic lymphoma kinase (ALK) rearrangement positive lung cancer was presented.
Non-small-cell Lung Cancer with Severe Skin Manifestations Related to Radiation Recall Dermatitis after Atezolizumab Treatment.
Kei Nakashima,Koichi Saruwatari,Ryo Sato,Kosuke Imamura,Ikko Kajihara,Satoshi Fukushima,Tetsuo Saito,Shiho Ishizuka,Daisuke Tamanoi,Takayuki Jodai,Shohei Hamada,Yusuke Tomita,Sho Saeki,Hidenori Ichiyasu,Natsuo Oya,Hironobu Ihn,Takuro Sakagami +16 more
TL;DR: Immunohistochemistry of the skin biopsy showed dermatitis with infiltration of CD8+ lymphocytes, suggesting that atezolizumab might provoke an immune-related inflammatory reaction at previously irradiated skin regions.
6